Abstract
Aim . To evaluate the impact of a clinical decision support system (CDSS) in the management of patients with hypertension (HTN) and atrial fibrillation (AF) on compliance with clinical guidelines in real-world clinical practice. Material and methods. A cluster-randomized comparative study was conducted in 8 internal medicine departments in Samara. The departments were randomized into two following groups: one with the CDSS for prescribing anticoagulant, antiarrhythmic, and antihypertensive therapy (n=3; 2 inpatient and 1 outpatient department) and one without the CDSS — routine clinical practice (n=5; 3 inpatient and 2 outpatient departments). The study included patients with both hypertension and AF. The mean follow-up period was 11,5±5,7 months. R e sults . The study included 272 patients. Prescription rate of reduced doses of direct oral anticoagulants was significantly lower in the CDSS group as follows: apixaban 2,5 mg (0,8% vs 4,4%, pConclusion . CDSS implementation demonstrated a significant improvement in physician compliance with clinical guidelines in terms of prescribing optimal anticoagulant and antiarrhythmic therapy. Patients were more frequently referred for catheter ablation of AF. CDSS is associated with a reduced incidence of CVEs in patients with hypertension and AF.

This publication has 33 references indexed in Scilit: